Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Background Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is
closely associated with metabolic conditions such as obesity and diabetes mellitus, which …

Significance: Nonalcoholic fatty liver disease (NAFLD) is a hepatic and systemic disorder
with a complex multifactorial pathogenesis. Owing to the rising incidence of obesity and …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …

Metabolic dysfunction‐associated steatotic liver disease (MASLD) typically presents with
hepatic fibrosis in advanced disease, resulting in increased liver stiffness. A subset of …

Background To reveal the role of branched-chain amino acids (BCAAs) in the development
and progression of nonalcoholic fatty liver disease (NAFLD) and the effect on the incidence …

Non-alcoholic fatty liver disease (NAFLD) is an umbrella term for a range of conditions
caused by a build-up of fat in the liver. It is usually seen in people who are overweight or …

Background. Asthma is one of the most common respiratory diseases and one of the largest
burdens of health care resources across the world. This study is aimed at using …

Non-alcoholic fatty liver disease (NAFLD) is closely related to metabolic syndrome and
remains a major global health burden. The increased prevalence of obesity and type 2 …

The liver-heart axis is a growing field of interest owing to rising evidence of complex
bidirectional interplay between the two organs. Recent data suggest non-alcoholic fatty liver …